IBDEI0MU ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10167,2)
 ;;=^5157366
 ;;^UTILITY(U,$J,358.3,10168,0)
 ;;=D23.111^^74^671^25
 ;;^UTILITY(U,$J,358.3,10168,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10168,1,3,0)
 ;;=3^Benign Eyelid Lesion,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,10168,1,4,0)
 ;;=4^D23.111
 ;;^UTILITY(U,$J,358.3,10168,2)
 ;;=^5157290
 ;;^UTILITY(U,$J,358.3,10169,0)
 ;;=D23.121^^74^671^26
 ;;^UTILITY(U,$J,358.3,10169,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10169,1,3,0)
 ;;=3^Benign Eyelid Lesion,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,10169,1,4,0)
 ;;=4^D23.121
 ;;^UTILITY(U,$J,358.3,10169,2)
 ;;=^5157292
 ;;^UTILITY(U,$J,358.3,10170,0)
 ;;=C44.1021^^74^671^27
 ;;^UTILITY(U,$J,358.3,10170,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10170,1,3,0)
 ;;=3^Malignant Eyelid Lesion,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,10170,1,4,0)
 ;;=4^C44.1021
 ;;^UTILITY(U,$J,358.3,10170,2)
 ;;=^5157253
 ;;^UTILITY(U,$J,358.3,10171,0)
 ;;=C44.1091^^74^671^28
 ;;^UTILITY(U,$J,358.3,10171,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10171,1,3,0)
 ;;=3^Malignant Eyelid Lesion,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,10171,1,4,0)
 ;;=4^C44.1091
 ;;^UTILITY(U,$J,358.3,10171,2)
 ;;=^5157255
 ;;^UTILITY(U,$J,358.3,10172,0)
 ;;=H02.132^^74^671^13
 ;;^UTILITY(U,$J,358.3,10172,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10172,1,3,0)
 ;;=3^Ectropion,Senile,Right Lower Eyelid
 ;;^UTILITY(U,$J,358.3,10172,1,4,0)
 ;;=4^H02.132
 ;;^UTILITY(U,$J,358.3,10172,2)
 ;;=^5004318
 ;;^UTILITY(U,$J,358.3,10173,0)
 ;;=H02.135^^74^671^14
 ;;^UTILITY(U,$J,358.3,10173,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10173,1,3,0)
 ;;=3^Ectropion,Senile,Left Lower Eyelid
 ;;^UTILITY(U,$J,358.3,10173,1,4,0)
 ;;=4^H02.135
 ;;^UTILITY(U,$J,358.3,10173,2)
 ;;=^5133414
 ;;^UTILITY(U,$J,358.3,10174,0)
 ;;=B02.8^^74^671^29
 ;;^UTILITY(U,$J,358.3,10174,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10174,1,3,0)
 ;;=3^Herpes Zoster w/o Complications
 ;;^UTILITY(U,$J,358.3,10174,1,4,0)
 ;;=4^B02.8
 ;;^UTILITY(U,$J,358.3,10174,2)
 ;;=^5000500
 ;;^UTILITY(U,$J,358.3,10175,0)
 ;;=G24.5^^74^672^32
 ;;^UTILITY(U,$J,358.3,10175,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10175,1,3,0)
 ;;=3^Blepharospasm
 ;;^UTILITY(U,$J,358.3,10175,1,4,0)
 ;;=4^G24.5
 ;;^UTILITY(U,$J,358.3,10175,2)
 ;;=^15293
 ;;^UTILITY(U,$J,358.3,10176,0)
 ;;=G43.909^^74^672^31
 ;;^UTILITY(U,$J,358.3,10176,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10176,1,3,0)
 ;;=3^Migraine Not Intractable w/o Status Migrainosus
 ;;^UTILITY(U,$J,358.3,10176,1,4,0)
 ;;=4^G43.909
 ;;^UTILITY(U,$J,358.3,10176,2)
 ;;=^5003909
 ;;^UTILITY(U,$J,358.3,10177,0)
 ;;=G93.2^^74^672^9
 ;;^UTILITY(U,$J,358.3,10177,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10177,1,3,0)
 ;;=3^Benign Intracranial Hypertension
 ;;^UTILITY(U,$J,358.3,10177,1,4,0)
 ;;=4^G93.2
 ;;^UTILITY(U,$J,358.3,10177,2)
 ;;=^5004180
 ;;^UTILITY(U,$J,358.3,10178,0)
 ;;=G51.0^^74^672^20
 ;;^UTILITY(U,$J,358.3,10178,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10178,1,3,0)
 ;;=3^CN7-Bell's Palsy
 ;;^UTILITY(U,$J,358.3,10178,1,4,0)
 ;;=4^G51.0
 ;;^UTILITY(U,$J,358.3,10178,2)
 ;;=^13238
 ;;^UTILITY(U,$J,358.3,10179,0)
 ;;=G51.4^^74^672^36
 ;;^UTILITY(U,$J,358.3,10179,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10179,1,3,0)
 ;;=3^Facial Myokymia
 ;;^UTILITY(U,$J,358.3,10179,1,4,0)
 ;;=4^G51.4
 ;;^UTILITY(U,$J,358.3,10179,2)
 ;;=^5003996
 ;;^UTILITY(U,$J,358.3,10180,0)
 ;;=H34.01^^74^672^11
